Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Pharmacological inhibition of bromodomain and extra-terminal proteins induces an NRF-2-mediated antiviral state that is subverted by SARS-CoV-2 infection

PLoS Pathogens(2023)10.1371/journal.ppat.1011657Source: DataRank Database

Pharmacological inhibition of bromodomain and extra-terminal proteins induces an NRF-2-mediated antiviral state that is subverted by SARS-CoV-2 infection is a research paper published in PLoS Pathogens (2023). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

refseq nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)OA: goldTopics (22)IDs (PubMed, PMC)Annotations (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (22)

Dylan Postmus ORCID,Saskia Stenzel ORCID,January Weiner ORCID,Jenny Jansen,Francisco J. Zapatero‐Belinchón ORCID

Live enrichment

PubMed:37747932 PMC:PMC10629670

Division of Intramural Research, National Institute of Allergy and Infectious Diseases

Grant: HHSN272201400008C

Berlin Institute of Health

Grant: IA56104004

Berliner Sparkassenstiftung Medizin

Grant: 2022-055

Stiftung Charité

Grant: WIS_PRO_652

Deutsche Forschungsgemeinschaft

Grant: SPP1923, GO2153/4

Bundesministerium für Bildung und Forschung

Grant: Organo-Strat 01KX2021

Deutsches Zentrum für Lungenforschung

Grant: 82DZL002A1

Bundesministerium für Bildung und Forschung

Grant: COVID-Protect, 01KI20143C

Deutsche Forschungsgemeinschaft

Grant: unidentified

unidentified

goldLicense: cc-by

publisherhttps://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1011657&type=printable

publisherhttps://dx.plos.org/10.1371/journal.ppat.1011657

repositoryhttps://edoc.mdc-berlin.de/id/eprint/23752/1/23752oa.pdf

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10629670/pdf/ppat.1011657.pdf

repositoryhttp://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-215392

Fields of Study

0301 basic medicine03 medical and health sciences

MeSH Terms

HumansInterferon Type IViral ProteinsAntiviral AgentsCOVID-19SARS-CoV-2

Keywords

Infectious MedicineQH301-705.5SARS-CoV-2COVID-19InfektionsmedicinRC581-607Antiviral AgentsViral ProteinsInterferon Type IHumansTechnology PlatformsImmunologic diseases. AllergyBiology (General)Research Article

Pharmacological inhibition of bromodomain and extra-terminal proteins induces an NRF-2-mediated antiviral state that is subverted by SARS-CoV-2 infection

FAIR Checklist

Authors (22)

Funding (9 grants)

Open Access

Topics

Annotations (Europe PMC)